Peripheral artery disease (PAD) is a manifestation of atherosclerosis occurring in the arteries of the upper or lower extremities, as well as the extracranial carotid, mesenteric, and renal circulation. CVrg’s PAD report focuses on PAD of the lower extremities (LE-PAD), which includes intermittent claudication and critical limb-threatening ischemia. PAD is highly prevalent and is associated with high cardiovascular risk but awareness for the condition remains poor, as evidenced by low diagnosis and treatment rates. Primary treatment of LE-PAD is mainly composed of revascularization of the affected limb and thus, most innovation has come from medical devices historically. However, drug companies have expressed a growing interest in exploring this untapped market.
CardioVascular Resource Group (CVrg) is a team of expert analysts who rigorously evaluate the latest new data releases, corporate reports, and news to distill important advances in complex therapeutic areas. Our comprehensive medical congress coverage and continuous market surveillance put these advances into the context of the overall PAD competitive landscape to help guide strategic and tactical commercial development decisions for our clients.
